Type II PtdIns 4-kinase β associates with CD4-p56lck complex and is involved in CD4 receptor signaling. 2014

Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 400076, India, ranjeet@scripps.edu.

Type II phosphatidylinositol (PtdIns) 4-kinases are involved in the synthesis of PtdIns 4-phosphates and modulate various cell functions like, intracellular signaling, cytoskeletal rearrangements, vesicular trafficking, and pathogen invasion. In CD3 receptor activated T cells, a type II PtdIns 4-kinase β is recruited to CD3 receptor zeta and plays a role in intracellular calcium release and probably in actin cytoskeleton reorganization. T cell receptor mediated activation is supported by CD4 receptor. The role of type II PtdIns 4-kinase β in CD4 receptor-mediated signaling was addressed in the present manuscript. Crosslinking of CD4 receptors with monoclonal antibodies showed an increase in CD4-associated PtdIns 4-kinase activity and requires p56(lck) activity. Biochemical characterization suggests that it belongs to type II PtdIns 4-kinase family. shRNA mediated knockdown of type II PtdIns 4-kinase β showed abrogation of CD4 receptor induced intracellular calcium release. These results suggest that type II PtdIns 4-kinase β plays an integral part in CD4 receptor-mediated signaling.

UI MeSH Term Description Entries
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015704 CD4 Antigens 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. They are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. T4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120. Antigens, CD4,CD4 Molecule,CD4 Receptor,CD4 Receptors,Receptors, CD4,T4 Antigens, T-Cell,CD4 Antigen,Receptors, Surface CD4,Surface CD4 Receptor,Antigen, CD4,Antigens, T-Cell T4,CD4 Receptor, Surface,CD4 Receptors, Surface,Receptor, CD4,Surface CD4 Receptors,T-Cell T4 Antigens,T4 Antigens, T Cell
D015778 Minor Histocompatibility Antigens Allelic alloantigens often responsible for weak graft rejection in cases when (major) histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen. Histocompatibility Antigens, Minor,Minor Histocompatibility Antigen,Minor Histocompatibility Peptide,Minor Histocompatibility Peptides,Antigen, Minor Histocompatibility,Histocompatibility Antigen, Minor,Histocompatibility Peptide, Minor,Histocompatibility Peptides, Minor,Peptide, Minor Histocompatibility
D017853 Phosphotransferases (Alcohol Group Acceptor) A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.
D019169 Jurkat Cells A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation. Cell, Jurkat,Cells, Jurkat,Jurkat Cell
D019860 Lymphocyte Specific Protein Tyrosine Kinase p56(lck) This enzyme is a lymphoid-specific src family tyrosine kinase that is critical for T-cell development and activation. Lck is associated with the cytoplasmic domains of CD4, CD8 and the beta-chain of the IL-2 receptor, and is thought to be involved in the earliest steps of TCR-mediated T-cell activation. Protein Tyrosine Kinase p56(lck),lck Kinase,p56 lck,Proto-Oncogene Protein c-lck,Proto-Oncogene Protein lck,Kinase, lck,Protein c-lck, Proto-Oncogene,Protein lck, Proto-Oncogene,Proto Oncogene Protein c lck,Proto Oncogene Protein lck,c-lck, Proto-Oncogene Protein,lck, Proto-Oncogene Protein

Related Publications

Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
December 1993, Molecular and cellular biology,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
November 1992, Molecular and cellular biology,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
October 1993, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
October 2001, The Journal of biological chemistry,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
February 1999, Indian journal of biochemistry & biophysics,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
February 2004, Biochemical and biophysical research communications,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
November 1994, The Journal of experimental medicine,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
January 2007, Immunology and cell biology,
Ranjeet Kumar Sinha, and Naveen Bojjireddy, and Deepak Kanojia, and Gosukonda Subrahmanyam
February 2006, Molecular immunology,
Copied contents to your clipboard!